Skip to content
Monday, October 12, 2026
Explore expert tips on digital marketing, content creation,…

Individuals Discontinuing Slimming Jabs Put On Weight Far More Rapidly Than People Using Diet and Exercise

Image of pharmaceutical syringe and scale
Obesity treatment involves long-term strategies.

New research suggests that individuals who discontinue new slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise regimens.

Research printed in a leading health publication shows that while overweight individuals can lose about a fifth of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"People using such medications must be aware of the potential of quick weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.

That rate of recovery implies a return to pre-treatment mass in about 18 months.

Comparing Treatments

The study, which reviewed 37 of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.

Researchers point out that people who lose weight through diet and exercise usually see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Experts believe the mechanism of the drugs is key to understanding the amplified weight return.

GLP-1 drugs copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its endogenous GLP-1, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this hormone supplement means appetite is uncontrolled, making binge eating far more likely."

A Lifelong Issue?

Health authorities suggest the injections for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

Professionals say that, due to the high risk of weight regain, the therapy might need to be long-term.

This view is reinforced by drug manufacturers, who note that the results "highlight the persistent character of obesity," comparing it to managing diseases like high blood pressure.

User Testimonies

Users who have stopped the jabs describe a sudden resurgence of cravings.

"It felt as if a switch flipping and I was suddenly starving," said an individual.

This challenge is exacerbated if individuals have not adopted permanent lifestyle or habit changes during therapy.

Significant Interest

Figures indicate that millions of adults in the UK have tried these injections in the past year, with desire being substantial.

  • Use is higher among females compared to men.
  • The middle-aged age group shows the highest usage rates.
  • Many access the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while these medications are potent tools for weight loss, they are not a magic solution and long-term success relies on ongoing behavioural changes.

By

Pamela Cruz

A digital strategist with over a decade of experience in content marketing and brand development, passionate about helping businesses grow online.

CreativeView

Type to search articles.